Riskpilot← Back to searchSign inGet full accessKVINTO AS
ASActiveOrg 983556205Wedel Jarlsbergs Vei 31, 1358 JarWholesale of pharmaceutical and medical goods · NACE 4646Est. 20015 employeeswww.kvinto.no
Revenue 2023
NOK 62,4M
+7% vs 2022
EBITDA margin
12.0%
+35% vs 2022
Equity ratio
48.1%
Financial strength
Net profit 2023
NOK 5,4M
+60% vs 2022
| Revenue | NOK 62,4M | +7% |
| EBITDA | NOK 7,5M | +35% |
| Net profit | NOK 5,4M | +60% |
| Total assets | NOK 23,1M | +12% |
| Equity | NOK 11,1M | +15% |
| Employees | 5 | — |
Legal name
KVINTO AS
Org number
983556205
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
30. juli 2001
Share capital
NOK 100 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Import, kjøp og salg av handelsvarer pr postordre samt oppsøkende salg, finansiering samt annen virksomhet i denne forbindelse.
Address
Wedel Jarlsbergs Vei 31, 1358 Jar
Phone
+4722720300
Email
post@kvinto.no
Website
www.kvinto.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 18 968 | 22 860 | 29 678 | 38 739 | 0 | 0 | 47 974 | 50 785 | 41 853 | 45 790 | 44 994 | 49 384 | 55 955 | 62 557 | 58 515 | 62 443 |
| Staff expenses | −0 | −2 640 | −3 071 | −3 758 | −4 511 | −0 | −0 | −6 104 | −5 576 | −5 706 | −6 119 | −5 285 | −5 704 | −4 889 | −6 226 | −5 852 | −6 463 |
| EBITDA | 0 | 5 092 | 4 929 | 7 063 | 10 176 | 0 | 0 | 9 491 | 2 269 | 2 860 | 5 481 | 5 110 | 3 398 | 2 548 | 6 334 | 5 541 | 7 492 |
| Depreciation & amort. | −0 | −29 | −31 | −31 | −17 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −269 | −188 | −132 |
| EBIT | 0 | 5 064 | 4 898 | 7 032 | 10 159 | 0 | 0 | 9 491 | 2 269 | 2 860 | 5 481 | 5 110 | 3 398 | 2 548 | 6 066 | 5 353 | 7 360 |
| Net financials | 0 | 19 | 108 | −98 | 211 | 0 | 0 | −345 | −344 | 159 | −114 | −113 | −571 | −291 | −275 | −1 007 | −412 |
| Profit before tax | 0 | 5 082 | 5 006 | 6 934 | 10 370 | 0 | 0 | 9 146 | 1 925 | 3 018 | 5 367 | 4 998 | 2 828 | 2 256 | 5 790 | 4 347 | 6 948 |
| Tax | −0 | 1 431 | 1 410 | 1 959 | 2 906 | −0 | −0 | 2 478 | 528 | 759 | 1 296 | 1 156 | 627 | 496 | 1 290 | 969 | 1 534 |
| Net profit | 0 | 3 652 | 3 595 | 4 975 | 7 463 | 0 | 0 | 6 668 | 1 397 | 2 259 | 4 071 | 3 841 | 2 201 | 1 761 | 4 501 | 3 378 | 5 413 |
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | 8 490 | 9 147 | 12 888 | 19 856 | — | — | 16 733 | 13 219 | 12 109 | 15 560 | 12 963 | 15 842 | 18 651 | 23 303 | 20 598 | 23 124 |
| Equity | — | 1 968 | 3 564 | 4 538 | 3 002 | — | — | 3 297 | 2 695 | 4 954 | 7 025 | 4 867 | 7 067 | 8 828 | 9 329 | 9 706 | 11 120 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 6 520 | 5 584 | 8 350 | 16 855 | 0 | 0 | 13 436 | 10 524 | 7 155 | 8 535 | 8 096 | 8 775 | 9 823 | 13 974 | 10 891 | 12 004 |
| Total debt | 0 | 6 522 | 5 584 | 8 350 | 16 855 | 0 | 0 | 13 436 | 10 524 | 7 155 | 8 535 | 8 096 | 8 775 | 9 823 | 13 974 | 10 891 | 12 004 |
EBITDA margin
12.0%
This company
15.8%
Market median
-24% vs market
20072023
Equity ratio
48.1%
This company
38.2%
Market median
+26% vs market
20072023
Return on equity
48.7%
This company
18.4%
Market median
+165% vs market
20072023
Net profit margin
8.7%
This company
8.1%
Market median
+7% vs market
20072023
Asset turnover
2.70×
This company
1.12×
Market median
+141% vs market
20072023
Debt / equity
1.08×
This company
0.62×
Market median
-74% vs market
20072023
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
- Annual report 2007Filed via Brønnøysundsregistrene · Period 2007-01-01 – 2007-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TR Chief Executive Officer | Chief Executive Officer | 2001 | — | — |
SE Deputy Member | Deputy Member | 2001 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2024 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairman | 2001 | — | — | |
| Board of Directors | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Onemed As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Onemed As
KVINTO AS Board members of KVINTO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Toril Røed | Chief Executive Officer | 0 companies |
| Svein Erik Røed | Deputy Member | 0 companies |
| Jan Knoph | Chairman | 0 companies |
| Jens Ole Ørneberg | Board of Directors | 0 companies |
| Ingunn Sanner | Chairman | 0 companies |
| Cecilie Louise Buøen | Board of Directors | 0 companies |